Form 4 holding
Director
Aquestive Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 99,486
- Estimated value
- $412,866
- Report date
- 10 Jun 2026
- Price
- $4.15
- Ownership
- Direct
John Cochran - Director at Aquestive Therapeutics, Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- AQST on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by John Cochran since 12 Aug 2025
Reported holdings for John Cochran in Aquestive Therapeutics, Inc.
Form 4 holding
Director
Aquestive Therapeutics, Inc.
- Security class
- Stock Option (Right to Purchase)
- Shares / value
- 50,500
- Estimated value
- $143,220
- Report date
- 10 Jun 2026
- Price
- $3.41
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for John Cochran in Aquestive Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.